Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
1 other identifier
observational
50
1 country
1
Brief Summary
The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for assessing skin thickness in SSc patients through patient-reported measurements. This study aimed to develop a Turkish version of the PASTUL questionnaire and to provide for its use in the Turkish population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2025
CompletedFirst Submitted
Initial submission to the registry
September 13, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 4, 2027
September 19, 2025
September 1, 2025
2 years
September 13, 2025
September 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) Questionnaire
The PASTUL survey is a simple assessment by the patient of the skin in eight areas of the upper extremities as normal, mildly, moderately, or severely thickened, corresponding to the mRSS assessment. The assessment score is consistent with the mRSS (0-3). A high score indicates increased skin thickness
Two weeks
Secondary Outcomes (7)
Scleroderma Health Assessment Questionnaire (SHAQ)
Two weeks
Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ)
Two weeks
Short Form-36 (SF-36)
Two weeks
Modified Rodnan skin score (MRSS)
Two weeks
Modified Hand Mobility in Scleroderma Test (mHAMIS)
Two weeks
- +2 more secondary outcomes
Study Arms (1)
Systemic sclerosis
Interventions
Eligibility Criteria
The study population will consist of individuals who come to the university hospital for routine controls.
You may qualify if:
- Individuals diagnosed with scleroderma,
- Individuals aged 18 years and older
You may not qualify if:
- Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
- Individuals who are unwilling to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Çankaya, Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PT, PhD(c)
Study Record Dates
First Submitted
September 13, 2025
First Posted
September 19, 2025
Study Start
August 4, 2025
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 4, 2027
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share